![Using median survival in meta-analysis of experimental time-to-event data | Systematic Reviews | Full Text Using median survival in meta-analysis of experimental time-to-event data | Systematic Reviews | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs13643-021-01824-0/MediaObjects/13643_2021_1824_Fig5_HTML.png)
Using median survival in meta-analysis of experimental time-to-event data | Systematic Reviews | Full Text
![7.6 Kaplan-Meier estimate of the survival function | Introduction to Regression Methods for Public Health Using R 7.6 Kaplan-Meier estimate of the survival function | Introduction to Regression Methods for Public Health Using R](https://www.bookdown.org/rwnahhas/RMPH/RMPH_files/figure-html/median-surv-time-1.png)
7.6 Kaplan-Meier estimate of the survival function | Introduction to Regression Methods for Public Health Using R
![Real-world time trends in overall survival, treatments and patient characteristics in HR+/HER2− metastatic breast cancer: an observational study of the SONABRE Registry - The Lancet Regional Health – Europe Real-world time trends in overall survival, treatments and patient characteristics in HR+/HER2− metastatic breast cancer: an observational study of the SONABRE Registry - The Lancet Regional Health – Europe](https://www.thelancet.com/cms/attachment/0b732d25-37b7-4d93-ad0b-8f60f96a958e/gr1.jpg)
Real-world time trends in overall survival, treatments and patient characteristics in HR+/HER2− metastatic breast cancer: an observational study of the SONABRE Registry - The Lancet Regional Health – Europe
![Kaplan-Meier curve for overall survival. The median survival time was... | Download Scientific Diagram Kaplan-Meier curve for overall survival. The median survival time was... | Download Scientific Diagram](https://www.researchgate.net/publication/321231754/figure/fig1/AS:569454109364224@1512779847201/Kaplan-Meier-curve-for-overall-survival-The-median-survival-time-was-650-months-95.png)
Kaplan-Meier curve for overall survival. The median survival time was... | Download Scientific Diagram
![Kaplan-Meier curves for overall survival. The median overall survival... | Download Scientific Diagram Kaplan-Meier curves for overall survival. The median overall survival... | Download Scientific Diagram](https://www.researchgate.net/publication/341170479/figure/fig2/AS:962781394255883@1606556380401/Kaplan-Meier-curves-for-overall-survival-The-median-overall-survival-was-180months-95.png)
Kaplan-Meier curves for overall survival. The median overall survival... | Download Scientific Diagram
![Predicting Mean Survival Time from Reported Median Survival Time for Cancer Patients - Mette L. Lousdal, Ivar Sønbø Kristiansen, Bjørn Møller, Henrik Støvring, 2017 Predicting Mean Survival Time from Reported Median Survival Time for Cancer Patients - Mette L. Lousdal, Ivar Sønbø Kristiansen, Bjørn Møller, Henrik Støvring, 2017](https://journals.sagepub.com/cms/10.1177/0272989X16655341/asset/images/large/10.1177_0272989x16655341-fig3.jpeg)
Predicting Mean Survival Time from Reported Median Survival Time for Cancer Patients - Mette L. Lousdal, Ivar Sønbø Kristiansen, Bjørn Møller, Henrik Støvring, 2017
![Brainstem Infiltration Predicts Survival in Patients With High-grade Gliomas Treated With Chemoradiotherapy | Anticancer Research Brainstem Infiltration Predicts Survival in Patients With High-grade Gliomas Treated With Chemoradiotherapy | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/41/5/2583/F1.large.jpg)
Brainstem Infiltration Predicts Survival in Patients With High-grade Gliomas Treated With Chemoradiotherapy | Anticancer Research
![Extent of resection and radiotherapy in GBM: A 1973 to 2007 surveillance, epidemiology and end results analysis of 21,783 patients Extent of resection and radiotherapy in GBM: A 1973 to 2007 surveillance, epidemiology and end results analysis of 21,783 patients](https://www.spandidos-publications.com/article_images/ijo/42/3/IJO-42-03-0929-g00.jpg)
Extent of resection and radiotherapy in GBM: A 1973 to 2007 surveillance, epidemiology and end results analysis of 21,783 patients
![Efficacy and Safety of Platinum Rechallenge in Patients With Platinum-resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer: A Multicenter Retrospective Study | Anticancer Research Efficacy and Safety of Platinum Rechallenge in Patients With Platinum-resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer: A Multicenter Retrospective Study | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/42/9/4603/F1.large.jpg)